Table 3.
Analyte | Electrode * | Technique * | Linear Range (µmol L−1) | LOD (µmol L−1) | Samples | Reference |
---|---|---|---|---|---|---|
Aflatoxin B1 | CB-SPE | DPV | 1.06 × 10−4–2.35 × 10−3 (buffer) and 1.82 × 10−4–4.99 × 10−3 (extract) | 4.16 × 10−5 (buffer) and 7.68 × 10−5 (extract) | Corn extract | [145] |
Domoic acid (DOA) | CB-SPE | Amperometry | 1.61 × 10−2–1.99 × 10−2 (buffer) 1.61 × 10−2–1.86 × 10−1 (scallop extract) |
1.28 × 10−3 (buffer) 2.25 × 10−3 (buffer) |
Buffer and Scallop extract | [142] |
Dopamine (DA) and Epinephrine (EP) | aGO/CB-OMNiDIP-adduct/SPCE | DPV | 7.57 × 10−4–4.07 × 10−2 (DA) and 4.04 × 10−4–9.99 × 10−3 (EP) | 1.83 × 10−4–3.98 × 10−4 (DA) 9.28 × 10−5–1.09 × 10−4 (EP) | Aqueous, blood serum, urine and pharmaceutical | [151] |
Dopamine (DA) Epinephrine (EP) and acetaminophen (ACP) |
SPCE/CB-ERGO | SWV | 4.9–19 (DA) 9.9–95 (EP) 9.9–95 (ACP) |
4.1 × 10−1 (DA) 1.8 (EP) 1.5 (ACP) |
Buffer | [150] |
Levofloxacin (LVF) and acetaminophen (ACP) | CB(BP4750)-SPE | SWV | 0.90–70.0 (LVF) 4.0–80.0 (ACP) |
0.42 (LVF) 2.6 (ACP) |
River water | [147] |
Na+ ions | CB-SPE | DPV | 1.0 × 103 and 1.0 × 106 | 63 | Sweat | [144] |
O-diphenols hydroxyty rosol (OLEU) and oleuropei (HYT) | CB-MoS2-SPE | DPV | 0.3–30 (OLEU) 2–100 (HYT) |
0.1 (OLEU) 1 (HYT) |
Olive oil | [148] |
Okadaic acid (OA) and domoic acid (DOA) |
CB-SPE | DPV | 1.28 × 10−2–2.31 × 10−1 (DOA in buffer), 1.28 × 10−2–1.09 × 10−1 (DOA in mussel extract), 3.35 × 10−4–4.10 × 10−3 (OA in buffer) and 4.35 × 10−4–4.84 × 10−3 (OA in mussel extract) | 5.46 × 10−3 (DOA in buffer), 6.10 × 10−3 (DOA in mussel extract), 1.86 × 10−4 (OA in buffer), and 2.24 × 10−4 (OA in mussel extract) | Buffer and Mussel Extract | [143] |
Spike protein (S) and nucleocapsid protein (N) | CB-SPE | DPV | --- | 19 ng mL−1 (S) 8 ng mL−1 (N) |
Saliva | [152] |
Uric acid | CB-GO-SPCE | Flow injection amperometry | 0.05–2000 | 0.01 | Urine | [149] |
* The explanations of the abbreviations in Table 3 can be found in the Supplementary Materials.